The disease can cause it to become harder and harder to breathe - and it's key you keep an eye out for symptoms ...
If you have a cough and are putting it down to 'just you' or 'that illness' you've had for weeks, you should see a GP, a ...
The "Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast - 2034" report has been added tAndMarkets.com's offering.The report delivers an in-depth understanding of the Cough in ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
The two positive studies mean that Boehringer can now seek approval for nerandomilast with a broad label claim in pulmonary ...
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
Qureight Ltd, the Core Imaging Laboratory developing deep-learning image analytics, and Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on developing inhaled therapies to treat ...
Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...
The following is a summary of “Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback